Affinity completes cGMP plant expansion
US CMO Affinity Life Sciences has completed the expansion of its manufacturing plant, adding capacity for cGMP lyophilisation and biomarker development.
Archives for January 3, 2011
“Particulate matter” cited in Luitpold and Cumberland recalls
US drugmakers Luitpold and Cumberland have both withdrawn injectable pharmaceutical products after contamination concerns.
BASi and Pharmasset forge new partnership
An agreement to provide exclusive toxicology services, pharmaceutical analysis and bioanalytical services are at the heart of a new partnership signed by life sciences company Bioanalytical Systems (BASi) and clinical-stage pharmaceutical company Pharmasset.
US FDA joins PIC/S after 5 year review
The US FDA has finally become a member of the Pharmaceutical Inspection Convention and Pharmaceutical Co-Operation Inspection Scheme (PIC/S) after a five-year application process.